Regeneron Pharmaceuticals REGN Treasury stock, shares (in shares)
Treasury stock, shares (in shares) at other companies
Other financials
Where this comes from
Reported directly by Regeneron Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:TreasuryStockCommonShares.
The official record: Regeneron Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Regeneron Pharmaceuticals's treasury stock, shares (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Regeneron Pharmaceuticals's treasury stock, shares (in shares)?
- Regeneron Pharmaceuticals (REGN) reported treasury stock, shares (in shares) of 34.7M in Q1 2026.
- How has Regeneron Pharmaceuticals's treasury stock, shares (in shares) changed year-over-year?
- Regeneron Pharmaceuticals's treasury stock, shares (in shares) increased by 16.8% year-over-year, from 29.7M to 34.7M.
- What is the long-term trend for Regeneron Pharmaceuticals's treasury stock, shares (in shares)?
- Over 3 years (2022 to 2025), Regeneron Pharmaceuticals's treasury stock, shares (in shares) has grown at a 14.2% compound annual growth rate (CAGR), from 22.6M to 33.7M.